A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting side effect of cancer treatment, yet the lack of predictive human models continues to hinder therapeutic progress. Here, we establish a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity in human iPSC-derived sensory neurons, suitable for high-throughput identification of neuroprotective compounds. Using this platform, we screen a library of 192 kinase inhibitors and identify 19 hits that commonly inhibit three STE20 kinases-MAP4K4, MINK1, and TNIK. Genetic knockdown studies reveal that multi-kinase inhibition of these kinases is required for neuroprotection against paclitaxel. Consistently, selective pharmacological inhibition of the identified STE20 kinases rescues paclitaxel-induced axon degeneration in iPSC-derived sensory neurons and primary human dorsal root ganglia (DRG) and preserves intraepidermal nerve fiber density in a mouse model of CIPN. Together, these findings establish a translational human sensory neuron platform that enables target validation and drug discovery for CIPN.

Authors

Institutions

Publication Details

Journal
Cell Reports Medicine
Published
2026-05-01
DOI
https://doi.org/10.1016/j.xcrm.2026.102787
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy

Mirra Chung, Benjamin M. Gyori, Q Wang, Rasheen Powell et al.
Cell Reports Medicine
Cancer Treatment and Pharmacology
article

A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy

Mirra Chung, Benjamin M. Gyori, Q Wang, Rasheen Powell, Ahmet Höke, Ilyas Singeç, Veselina Petrova, Shannon Zhen, Aysel Cetinkaya‐Fisgin, Peter Karl Sorger, Riki Kawaguchi, Marian Kalocsay, Jen Splaine, Harathi Jonnagaddala, Sepideh Fouladzadeh, Lee B. Barrett, Caitlin E. Mills, Clemens Hug, Jennifer A. Smith, Gary A. Bradshaw, Clifford J. Woolf, Sara Hakim, Tao Deng
article en

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting side effect of cancer treatment, yet the lack of predictive human models continues to hinder therapeutic progress. Here, we establish a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity in human iPSC-derived sensory neurons, suitable for high-throughput identification of neuroprotective compounds. Using this platform, we screen a library of 192 kinase inhibitors and identify 19 hits that commonly inhibit three STE20 kinases-MAP4K4, MINK1, and TNIK. Genetic knockdown studies reveal that multi-kinase inhibition of these kinases is required for neuroprotection against paclitaxel. Consistently, selective pharmacological inhibition of the identified STE20 kinases rescues paclitaxel-induced axon degeneration in iPSC-derived sensory neurons and primary human dorsal root ganglia (DRG) and preserves intraepidermal nerve fiber density in a mouse model of CIPN. Together, these findings establish a translational human sensory neuron platform that enables target validation and drug discovery for CIPN.

Cell Reports Medicine
Boston Children's Hospital (US), Northeastern University (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), Longwood University (US), Johns Hopkins University (US), University of California, Los Angeles (US), Johns Hopkins Medicine (US), National Center for Advancing Translational Sciences (US), Center for Systems Biology (US)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, National Institute of Neurological Disorders and Stroke, Defense Sciences Office, DARPA
Openalex Percentile: Top 8%
Cancer Treatment and Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.